gvtcx

PHE-Scientific-HIV-1 LAg Avidity Kits (National Surveillance Programme)

Public Health England Published 18 Nov 2016 Contracts Finder

key details

Value£30,000
Statuscomplete
Category (CPV) 85145000
Deadline24 Jun 2015
Contract start24 Jun 2015
Contract end24 Jun 2016
SME suitableYes
OCIDocds-b5fd17-d00d2de5-adc8-11e6-9901-0019b9f3037b

Award

SupplierValueDateStatus
Sedia Biosciences £30,000 23 Jun 2015 active

description

This will be ongoing as part of national surveillance programme. A change in the national surveillance programme for recent HIV infections or a development of a new assays that better fulfils the requirements of

the survey will bring this to an end.

This assay is only available from one supplier. It has been identified through testing to be the most suitable for the needs of the national programme. Alternative assays have not performed as well as this one. The assay has been licensed to this company by the US CDC. This assay has been developed by the US CDC. It has undergone independent evaluation by the Consortium for the evaluation and performance of HIV Incidence assays and has been shown to have the lowest false recent rate and an acceptable mean duration of recency.

Being specifically manufactured for the purpose of identifying

recent infection it has better quality control than other modified assays that are not designed for this purpose therefore as a national laboratory we should be using the most appropriate assay.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
23 Sept 2015 Award (award) · ocds-b5fd17-d00d2de5-adc8-11e6-9901-0019b9f3037b-75104-ecm_3033

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.